Article
A Mendelian Randomization Study of Metabolite Profiles, Fasting Glucose, and Type 2 Diabetes.
Diabetes - 1 Nov 2017
Liu Jun, van Klinken Jan Bert, Semiz Sabina, van Dijk Ko Willems, Verhoeven Aswin, Hankemeier Thomas, Harms Amy C, Sijbrands Eric, Sheehan Nuala A, van Duijn Cornelia M, Demirkan Ayşe
Abstract excerpt
Mendelian randomization (MR) provides us the opportunity to investigate the causal paths of metabolites in type 2 diabetes and glucose homeostasis. We developed and tested an MR approach based on genetic risk scoring for plasma metabolite levels, utilizing a pathway-based sensitivity analysis to control for nonspecific effects. We focused on 124 circulating metabolites that correlate with fasting glucose in the...
Topics
Join the communities discussing this publication.
